Skip directly to page options Skip directly to A-Z link
Volume 17, Number 8—August 2011
Dispatch

Poliomyelitis Outbreak,Pointe-Noire, Republic of the Congo, September 2010–February 2011

Arnaud Le MenachComments to Author , Augusto E. Llosa, Isabelle Mouniaman-Nara, Felix Kouassi, Joseph Ngala, Naomi Boxall, Klaudia Porten, and Rebecca F. Grais
Author affiliations: Author affiliations: Health Protection Agency, London, UK (A. Le Menach, N. Boxall); European Centre for Disease Control and Prevention, Stockholm, Sweden (A. Le Menach); Epicentre, Paris, France (A.E. Llosa, K. Porten, R. F. Grais); Médecins Sans Frontières, Paris (I. Mouniaman-Nara, F. Kouassi); Médecins Sans Frontières, Brazzaville, Republic of the Congo (I. Mouniaman-Nara, F. Kouassi); Ministry of Health, Pointe-Noire, Republic of the Congo (J. Ngala)

Main Article

Table 1

Persons vaccinated against poliomyelitis (routine vaccination), by age and gender, Mbota, Pointe-Noire, Republic of the Congo, December 2010

Age, y, and gender No. (%) persons*
 Total no. persons
Vaccinated, card Vaccinated, recall Total vaccinated Nonvaccinated Unknown
<5
M 43 (35.5) 67 (55.4) 110 (90.9) 5 (4.1) 6 (5) 121
F 54 (36.2) 72 (48.3) 126 (84.5) 9 (6) 14 (9.4) 149
Total
 97 (35.9)
 139 (51.5)
 236 (87.4)
 14 (5.2)
 20 (7.4)
 270
5–9
M 26 (25.5) 53 (52) 79 (77.5) 10 (9.8) 13 (12.8) 102
F 23 (20.9) 66 (60) 89 (80.9) 7 (6.4) 14 (12.7) 110
Total
 49 (23.1)
 119 (56.1)
 168 (79.2)
 17 (8)
 27 (12.7)
 212
10–14
M 7(7.2) 62 (63.9) 69 (71.1) 9 (9.3) 19 (19.6) 97
F 16 (16) 51 (51) 67 (67) 7 (7) 26 (26) 100
Total
 23 (11.7)
 113 (57.4)
 136 (69.1)
 16 (8.1)
 45 (22.8)
 197
15–19
M 4 (4.4) 39 (42.4) 43 (46.8) 9 (9.8) 40 (43.5) 92
F 8 (7.3) 49 (45) 57 (52.3) 12 (11) 40 (36.7) 109
Total
 12 (6)
 88 (43.8)
 100 (49.8)
 21 (10.4)
 80 (39.8)
 201
20–24
M 2 (3) 25 (37.3) 27 (40.3) 7 (10.5) 33 (49.3) 67
F 4 (3.2) 61 (48) 65 (51.2) 14 (11) 48 (37.8) 127
Total
 6 (3.1)
 86 (44.3)
 92 (47.4)
 21 (10.8)
 81 (41.8)
 194
25–29
M 2 (2.3) 37 (43) 39 (45.3) 12 (14) 35 (40.7) 86
F 11 (10.4) 50 (47.2) 61 (57.6) 15 (14.2) 30 (28.3) 106
Total
 13 (6.6)
 87 (45.3)
 100 (51.9)
 27 (14.1)
 65 (33.9)
 192
>29
M 4 (1.5) 80 (29.2) 84 (30.7) 33 (12) 157 (57.3) 274
F 11 (4.2) 84 (32.3) 95 (36.5) 30 (11.5) 135 (51.9) 260
Total
 15 (2.8)
 164 (30.7)
 179 (33.5)
 63 (11.8)
 292 (54.7)
 534
Totals
M 88 (10.5) 363 (43.3) 451 (53.8) 85 (10.1) 303 (36.1) 839
F 127 (13.2) 433 (45.1) 560 (58.3) 94 (9.8) 307 (32) 961
Total 215 (11.9) 796 (44.2) 1,011 (56.1) 179 (10) 610 (33.9) 1,800

*Card, vaccination documented by card; recall, person remembers received vaccination; total, card + recall.

Main Article

References
  1. Grard  G, Drexler  JF, Lekana-Douki  S, Caron  M, Lukashev  A, Nkoghe  D, Type 1 wild poliovirus and putative enterovirus 109 in an outbreak of acute flaccid paralysis in Congo, October–November 2010. Euro Surveill. 2010;15:pii:19723.
  2. Roberts  L. Infectious disease. Polio outbreak breaks the rules. Science. 2010;330:1730–1. DOIPubMedGoogle Scholar
  3. Centers for Disease Control and Prevention. Poliomyelitis outbreak—Republic of the Congo, September 2010–February 2011. MMWR Morb Mortal Wkly Rep. 2011;60:312–3.PubMedGoogle Scholar
  4. Global Polio Eradication Initiative. Strategy. 2010 [cited 2010 Nov 22]. http://www.polioeradication.org/Aboutus/Strategy.aspx
  5. World Health Organization. Immunization surveillance, assessment and monitoring. 2011 [cited 2011 Jan 12]. http://www.who.int/immunization_monitoring/en/
  6. Heraut  L, Rousseau  E, Aubry  P. Poliomyelitis epidemic at Pointe-Noire [in French]. Med Trop (Mars). 1969;29:362–4.PubMedGoogle Scholar
  7. Gawne  AC, Halstead  LS. Post-polio syndrome: pathophysiology and clinical management. Crit Rev Phys Rehabil Med. 1995;7:147–88.
  8. Weinstein  L. Influence of age and sex on susceptibility and clinical manifestations in poliomyelitis. N Engl J Med. 1957;257:47–52. DOIPubMedGoogle Scholar
  9. Weinstein  L, Shelokov  A, Seltser  R, Winchell  GD. A comparison of the clinical features of poliomyelitis in adults and in children. N Engl J Med. 1952;246:297–302. DOIPubMedGoogle Scholar
  10. Froeschle  JE, Feorino  PM, Gelfand  HM. A continuing surveillance of enterovirus infection in healthy children in six United States cities. II. Surveillance enterovirus isolates 1960–1963 and comparison with enterovirus isolates from cases of acute central nervous system disease. Am J Epidemiol. 1966;83:455–69.PubMedGoogle Scholar
  11. Alexander  JP Jr, Gary  HE Jr, Pallansch  MA. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis. 1997;175(Suppl 1):S176–82. DOIPubMedGoogle Scholar
  12. Sidley  P. Seven die in polio outbreak in Namibia. BMJ. 2006;332:1408. DOIPubMedGoogle Scholar
  13. Outbreak of poliomyelitis, Cape Verde. Wkly Epidemiol Rec. 2000;75:401.PubMedGoogle Scholar
  14. Nathanson  N, Kew  OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol. 2010;172:1213–29. DOIPubMedGoogle Scholar

Main Article

Page created: August 16, 2011
Page updated: August 16, 2011
Page reviewed: August 16, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external